IWILFIN - Partners in Protection

IWILFIN - Partners in Protection IWILFIN® (eflornithine)
Please see Important Safety Information and Patient Information at www.iwilfin.com.

06/18/2026

DFMO. Eflornithine. Difluoromethylornithine. IWILFIN.

You may hear several names throughout the treatment journey, but they are all connected.

IWILFIN contains the active ingredient DFMO, also known as eflornithine.

Understanding treatment terminology can help caregivers feel more informed during conversations with the care team.

06/16/2026

Different names. One connected therapy.

IWILFIN contains the active ingredient DFMO, also known as eflornithine.

DFMO = active ingredient
IWILFIN = branded therapy


06/12/2026

For families facing high-risk neuroblastoma (HRNB), there are resources available to help manage the challenges of daily life. To learn more, explore advocacy groups at https://bit.ly/3QTDRGA

Please see the full Prescribing Information and Patient Information at https://bit.ly/41NMQeQ

You may hear both “DFMO” and “IWILFIN” during treatment conversations. Swipe through to better understand the connection...
06/09/2026

You may hear both “DFMO” and “IWILFIN” during treatment conversations. Swipe through to better understand the connection between the two terms.

06/04/2026

This Cancer Survivors Month, IWILFIN (eflornithine) honors the children who have faced high-risk neuroblastoma (HRNB) with extraordinary courage. Inspired by 2 survivors, Will and Finn, whose journeys and strength helped pave the way for a breakthrough maintenance therapy. Learn more at https://bit.ly/42jpYUH

Please see the full Prescribing Information and Patient Information at https://bit.ly/4sRB9i9

05/28/2026

Remission is something to celebrate. It can bring both relief and new questions about the future. For families facing high-risk neuroblastoma (HRNB), staying informed and being prepared can make a meaningful difference. IWILFIN (eflornithine) is here to support families for what comes next. To learn more, visit https://bit.ly/4sOoe0z

Please see the full Prescribing Information and Patient Information at https://bit.ly/41MGht8

05/20/2026

For families facing high-risk neuroblastoma (HRNB), hearing the words "remission accomplished" brings a well-earned sigh of relief. It's important to know that the journey doesn't stop at remission; it evolves. Visit https://bit.ly/42pX5Gk to learn how IWILFIN (eflornithine) can help children with HRNB stay in remission.

Please see full Prescribing Information and Patient Information at https://bit.ly/4sPq955

05/11/2026

Pediatric oncology nurses partner with families facing high-risk neuroblastoma (HRNB). They hold hands, answer questions, and bring comfort during the most difficult moments. This National Nurses Week, we honor pediatric oncology nurses.

03/09/2026

Their journeys began separately — but their purpose became one.

Discover how two families helped spark a breakthrough in childhood cancer treatment.

Because every child deserves a future.

Research: Beat Childhood Cancer

This Rare Disease Day, we honor the strength of patients and families navigating rare conditions with courage every day....
02/28/2026

This Rare Disease Day, we honor the strength of patients and families navigating rare conditions with courage every day.

Rare diseases may affect small populations, but the impact is profound. The need for awareness, research, and support is immense.

We stand with the rare disease community in recognizing every story, every challenge, and every step forward.

Because rare deserves to be seen.

Address

4441 Springdale Road
Louisville, KY
40241

Website

,

Alerts

Be the first to know and let us send you an email when IWILFIN - Partners in Protection posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category